Germany Hits Pause “Again” on AstraZeneca After 9 Deaths, 31 Reports of Rare Blood Clots
German health officials today suspended use of AstraZeneca's COVID vaccine for people under 60 as a “precautionary measure,” stating that people needed to “treat it carefully and wait for the talks taking place at the federal level.”
Authorities in Munich and Berlin today suspended the use of AstraZeneca’s COVID vaccine for those under 60 after Germany’s vaccine regulator reported 31 cases of a rare brain blood clot, nine of which resulted in deaths, ABC News reported.
All but two of the cases involved women 20 to 63 years old, according to the Paul Ehrlich Institute.
Germany’s federal health minister, Jens Spahn, said seven cases of cerebral vein thrombosis had been reported and that Germany’s vaccine authority, the Paul Ehrlich Institute, considered “further investigation necessary after new reports of cerebral brain thrombosis in connection with vaccination in Germany and Europe.”
In just the USA, UK and Europe there are 6,599 deaths after the experimental injection that have been "reported." And hundreds of thousands of side affects and many of them serious and life altering.
Unites States update*
VAERS data released today showed 44,606 reports of adverse events following COVID vaccines, including 2,050 deaths and 7,095 serious injuries between Dec. 14, 2020 and March 19, 2021.
United Kingdom update*
The MHRA has received 585 UK reports in which the patient died shortly after vaccination.
Up to and including 14 March 2021, the MHRA received and analysed 116,307 from people who have had adverse reactions shortly after the vaccine.
Rest of Europe**
3,964 Dead, 162,610 Injuries: European Database of Adverse Drug Reactions for COVID- 19. They were from three companies, AZ, Pfizer and Moderna.
*The first two programs are voluntary by people experiencing an adverse effect or the family of the deceased, the hospitals or coroners do not report. Thus, it is believed but not proven that only 10% are reported.
**REPORTS ARE SUBMITTED ELECTRONICALLY TO EUDRAVIGILANCE BY NATIONAL MEDICINES REGULATORY AUTHORITIES AND BY PHARMACEUTICAL COMPANIES THAT HOLD MARKETING AUTHORISATIONS (LICENCES) FOR THE MEDICINES.
We have nothing like this in Canada. We should, I hear many stories of severe reactions and deaths from Alberta and Saskatchewan but nothing I can confirm. Anyone want a job?